CoChat

Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm

Kemp, J P, Dockhorn, R J, Busse, W W, Bleecker, E R, Van As, A · 1994 · American journal of respiratory and critical care medicine

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Physical exercise is a common trigger for bronchial asthma. We evaluated the preventive effect on exercise-induced bronchospasm (EIB) of a single 42 micrograms dose of salmeterol, a uniquely long-acting inhaled bronchodilator, and compared salmeterol with 180 micrograms albuterol in two independent, randomized, double-blind, placebo-controlled studies involving 161 subjects. Three exercise challenges were conducted over 12 h, and bronchoconstriction following the serial challenges was assessed as change in FEV1 compared with predose values. The mean maximal percentage decrease in FEV1 after the three exercise challenges was 5% at 0.5 h, 8% at 5.5 h, and 13% at 11.5 h postdose in the salmeterol group compared with 7, 25, and 27%, respectively, in the albuterol group and 27, 27, and 26%, respectively, in the placebo group (p < 0.001, overall treatment difference). Albuterol provided complete protection against EIB (defined as < 10% decrease in FEV1 compared with predose values) only after the first exercise challenge, but salmeterol continued to provide complete protection in the majority of subjects after each exercise challenge: 80% (44 of 55) at 0.5 h, 70% (37 of 53) at 5.5 h, and 55% (29 of 53) at 11.5 h. Electrocardiographic monitoring revealed no clinically significant changes in any treatment group 15 and 30 min following each exercise challenge. In summary, these data demonstrate that salmeterol is effective against EIB and that a single 42 micrograms dose can prevent EIB for up to 12 h.

Overview

Integrity signals

Registry

Crossref · 10.1164/ajrccm.150.6.7952623

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

See all 85

Metadata

Authors
Kemp, J. P., Dockhorn, R. J., Busse, W. W., Bleecker, E. R., & Van As, A.
Affiliations
  • Allergy and Asthma Medical Group and Research Center (US)
  • Allergy and Asthma Medical Group and Research Center, San Diego, California 92123
Venue
American journal of respiratory and critical care medicine
Published
1994-12-01
Volume
150
Issue
6
Pages
1612-1615
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2078534806
Cited by
85
References
13
Citations by year
2024: 1 · 2019: 1 · 2018: 2 · 2016: 2 · 2014: 1 · 2013: 1
FWCI
5.14
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
Keywords
salmeterol, exercise-induced bronchoconstriction, asthma, salbutamol, inhaled bronchodilators, long-acting beta2-agonists, bronchoconstriction, exercise challenge, FEV1, single-dose prophylaxis
MeSH terms
Salmeterol Xinafoate, Administration, Inhalation, Adrenergic beta-Agonists, Adult, Albuterol, Analysis of Variance, Asthma, Exercise-Induced, Bronchodilator Agents, Double-Blind Method, Female, Forced Expiratory Volume, Humans, Male, Time Factors, Bronchoconstriction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm. https://app.cochat.ai/papers/10.1164/ajrccm.150.6.7952623
The paper
Kemp, J. P., Dockhorn, R. J., Busse, W. W., Bleecker, E. R., & Van As, A. (1994). Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm. American journal of respiratory and critical care medicine. https://doi.org/10.1164/ajrccm.150.6.7952623

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.